Referanser
1. Kvien TK, Glennås A, Knudsrød OG, Smedstad LM, Mowinckel P, Førre Ø. The prevalence and severity og rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol 1997;26:412-8
2. Söderlin MK, Börjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002;61:911-915
3. Uhlig TK, Kvien TK, Glennås A, Smedstad LM, Mowinckel P, Forre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998;25:1078-84
4. Svendsen, Holm, Kyvik, Hyltoft Petersen, Junker: Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ 2002;324:264-6
5. Silman AJ. Commentary: Do genes or environment influence development of rheumatoid arthritis. BMJ 2002;324:267-8
6. Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Muryoi T, Funato T, Nakamura M, Sugamura K, Sasaki T. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999;58:130
7. Peterlana D, Puccetti A, Beri R, Ricci M, Simeoni S, Borgato L, Scilanga L, Ceru S, Corrocher R, Lunardi C. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol. 2003;30:1907-10
8. Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev. 2004;3:362-7
9. Starkebaum G. Rheumatoid arthritis, methotrexat, and lymphoma: Risk substitution, or cat and mouse with Epstein-Barr virus? J Rheumatol. 2001;28:2573-5
10. Karlson EW, Mandl LA, Aweh GN, Grodstein F. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 2003;48:3055-60
11. Uhlig T. Revmatoid artritt. Tidsskrift Nor Lægeforen 2001;121:86
12. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-841
13. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, JS Smolen. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-297
14. Uhlig T, Kvien TK, Jensen IL, Axéll T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:415-22
15. http://www.rikshospitalet.no/view/readavdi.asp?nPubID=3048
16. Romi F, Vedeler C, Tysnes OB, Mørk S, Aarli JA. Polynevropati er et tidlig funn ved primær systemisk amyloidose. Tidsskr Nor Lægeforen 2000;120:1291
17. Baubion N, Vacheron A, Heulin A, Gilles R, LeSourd P, Le Parc JM, Di Matteo J. Constrictive pericarditis and rheumatoid arthritis. Arch Mal Coeur Vaiss. 1979 Sep;72(9):1023-8
18. Jurik AG, Graudal H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int. 1986;6:37-42
19. Chou CW, Chang SC. Pleuritis as a prsenting manifestation of rheumatoid arthritis: diagnostic clues in pleural fluid cytology. Am J Med Sci. 2002;323:158-61
20. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW. How to diagnose rheumatoid arthritis early. A prediction modell for persistent (erosiv) arthritis. Arthritis Rheum 2002;46:357-365
21. Jansen LMA, D van Schaardenburg, IE van der Horst-Bruinsma, BAC Dijkmans. One year outcome of udifferentiated polyarthritis. Ann Rheum Dis 2002;61:700-703
22. http://www.sarkoidose.no/pdf/Leddsmerter.pdf
23. Finsen V, Sandbu H. Injeksjonsbehandling ved triggerfinger. Tidsskr Nor Lægeforen 2001;121:3406-7
24. Bekkelund SI, Pierre-Jerome C. Karpaltunnelsyndrom. Tidsskr Nor Lægeforen 2001;121:2829-31
25. Gjerstad L, Hunsbeth Skjeldal O, Helseth E. Nevrologi og nevrokirurgi. s 246-7
26. http://www.furst.no/h271.html
27. www.stolav.no/stolav/resources/leddforedrag_typer_rontgenforandringer.ppt
28. Editorial. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study. Rheumatology 2004;43:819-820
29. http://www.helse-bergen.no/avd/ergoterapi/diagnose/Leddgikt+.htm
30. Miggiano GA, Gagliardi L. Diet, nutrition and rheumatoid arthritis. Clin Ter 2005;156:115-23
31. http://www.orf.no/revsyk/kosthold.html
32. Cristophersen OA, Haug A. Kosthold og smerte. Tidsskr Nor Lægeforen 2005;125:1219
33. Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:208-14
34. Kjeldsen-Kragh J. Mediterranean diet intervention in rheumatoid arthritis. Annals of the Rheumatic Diseases 2003;62:193-195
35. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek, M, Mowinkel P et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338:899-902
36. Kjeldsen-Kragh J. Rheumatoid arthritis treated with vegetarian diets. Am J Clin Nutr 1999;70:594-600
37. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther K-P, Hauselmann HJ, Herrero-Beaumont G, Jordan K; Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatoja R, Verbruggen G, Zimmermann-Gorska I, Dougados M. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Commitee for International Clinical Studies Including Therapeutics (ESCIST) Ann Rheum Dis 2005;64:669-681
38. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev. 2003;(1):CD000189
39. Strand V, Simon LS. Low dose glucocorticoids in early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:S186-90
40. Johnsen V, Førre Ø, Haga HJ, Kvien TK, Mikkelsen K, Nordvåg BY, Rødevand E. Kombinasjonsterapi ved revmatoid artritt. Tidsskr Nor Lægeforen 2003;123:1511-1
41. Wallenius M, Rødevand E, Skomsvoll JF. Klinisk erfaring med TNF- α-hemmere ved revmatoid artritt. Tidsskr Nor Lægeforen 2005;125:1664-6
42. Endresen GK, Husby G. Methotrexate and folates in rheumatoid arthritis. Tidsskr Nor Laegeforen. 1999;119:534-7
43. Starkebaum G. Rheumatoid arthritis, methotrexat, and lymphoma: Risk substitution, or cat and mouse with Epstein-Barr virus? J Rheumatol. 2001;28:2573-5
44. Maddison P, Kiely P, Lawson T, Moots R, Proudfoot D, Reece R, Scott D, Sword R, Taggart A, Thwaites C, Williams E. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus. Rheumatology (Oxford). 2005;44:280-6
45. Townsend HB, Saag KG. Glucocorticoid use in rheumatoid arthritis: benefits, mechanism, and risks. Clin Exp Rheumatol. 2004;22:S77-82
46. McCarey DW, McInnes IB, Madhok R et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): Double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21
47. Finsen V, Sandbu H. Injeksjonsbehandling ved triggerfinger. Tidsskr Nor Lægeforen 2001; 121: 3406-7
48. http://www.revmatiker.no/oslo/rheuma.nsf/Attachments/r205selolje.pdf/$FILE/r205selolje.pdf
49. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481-94.
50. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl 2004;69:3-8
51. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:e9016-17
52. Goodson N, Symmons D. Rheumatoid arthritis in women: still associated with an increased mortality. Ann Rheum Dis 2002;61:955-956
53. Goodson NJ, Marks J, Lunt M, Symmons DP. Cardiovascular admission and mortality in an inception cohort of patients with rheumatoid arthritis with an onset in the 1980´s and 1990´s. Ann Rheum Dis 2005;20
54. Farzaneh-Far A, Roman MJ. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract 2005;59:823-4
55. Peltomaa R, Paimela L, Kautiainen H, Leirisalo-Repo M. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 2002;61:889-894
56. Book C, Saxne T, Jacobsson LT. Prediction of mortality in rheumatoid arthritis based on diease activity markers. J Rheumatol 2005;32:430-4
57. Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, Cerhan JR. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women´s Health Study. Ann Rheum Dis 2002;61:994-999
58. Smolen JS, Breedveld FC, Eberl G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight-joint count for assessment of rheumatoid arthritis activity. Arthritis Rheum 1995;38:38-43
59. Prevoo ML, van´t Hof MA, Kuper HH, van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Developement and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8
62. Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analysis in 2,491 rheumatoid patients following leflunomide initiation. J Rheumatol. 2001;28:982-9
66. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo county Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522-30
67. Glennås A, Kvien TK, Melby K. Diagnostisk utredning av mistenkt reaktiv artritt. Tidsskr Nor Lægeforen 1995;115:2656-8
68. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology 2003;42:652-659
69. http://www.lommelegen.no/art/art615.asp
70. http://www.slidgigt.dk/Behandling/default.aspx?ArtikelID=Kosttilskud
71. Cho SH, Jung YB, Seong SC, Park HB, Byun KY, Lee DC, Song EK, Son JH. Clinical efficiacy and safety of Lyprinol, a patended extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Allerg Immunol 2003;35:212-6